Sort by
Refine Your Search
-
Listed
-
Field
-
antibodies and CART cells, in acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL). As a successful candidate you will: · Lead projects by designing and
-
/surgeons to plan, design, and execute computational analyses. Advance the integration of multi-omics and clinical datasets to uncover mechanisms of tumor evolution, therapeutic resistance, and potential
-
, and CAR-T and CAR-NK. As a successful candidate, you will: · Lead projects by designing and performing experimental procedures · Manage data, analyze, and report findings · Write
-
of novel cancer therapeutics. For more information about Dr. Perry’s lab, please visit here. As a successful candidate, you will: Devise, plan, document, and advance basic science-based projects in
-
information about Dr. Vu Ngo’s research, please visit here . As a successful candidate, you will: Plan, design, and execute experiments independently and in collaboration with lab members. Generate data
-
qualifications should include: PhD in Immunology or Cancer Biology: Backed by a strong publication record in peer-reviewed scientific journals. Translational Research Expertise: Proficiency in designing and
-
and to develop research publications and presentations, independent grant applications, and independent projects that they can take with them when they leave the lab Design, perform and lead projects
-
: · Effectively develop a project in a translational research environment in order to successfully meet project goals. · Design and execute experiments, critically interpret experimental results, and
-
successful candidate, you will: Design and execute experiments to advance research goals. Maintain detailed experiment logs from conception to analysis. Prepare laboratory reagents, chemicals, instruments, and
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology